FDA Approves Steglujan (ertugliflozin and sitagliptin) for Type 2 Diabetes

Article Link: FDA Approves Steglujan (ertugliflozin and sitagliptin) for Type 2 Diabetes

KENILWORTH, N.J. & NEW YORK–(BUSINESS WIRE) December 22, 2017 –Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Pfizer Inc. (NYSE:PFE), today announced that the U.S. Food and Drug Administration (FDA) has approved…

Source: FDA New Drug Approvals